Infectious Diseases News

The investigational antiviral ziresovir showed promise for the treatment of respiratory syncytial virus infection in infants during a phase 3 trial in China, researchers reported in The New England Journal of Medicine.

The FDA approved FluMist, a nasal spray vaccine, for self-administration in people aged 2 to 49 years, making it the first ever influenza vaccine that does not need to be administered by a health care professional, the FDA announced.

An additive for disinfectant wipes that initially appears blue on surfaces and disappears after cleaning led to a significant improvement in cleanliness during a trial at a hospital, researchers reported.

Without improvements to access and delivery of health care, more than 39 million people may die because of antimicrobial-resistant bacterial infections between 2025 and 2050, according to new estimates.

From 2010 to 2020, less than half of perinatally exposed infants were tested for hepatitis C virus, according to a study, but experts are hopeful that new early testing guidelines will ensure more infants are screened and treated.

The FDA on Friday approved the first ever influenza vaccine that does not have to be given by a health care professional.

Vaccine coverage among military children is higher than the national average, but there are unique barriers that prevent military children from receiving their childhood vaccinations on time, according to findings published in Pediatrics.

Almost one-third of people do not plan on receiving recommended vaccinations this fall, according to the results of a recent survey from the Ohio State University Wexner Medical Center.

The antiviral molnupiravir modestly reduces the risk for severe symptoms of COVID-19 and may also reduce the risk for long COVID, according to a randomized controlled trial.

A household contact of a person in Missouri confirmed to be infected with H5 avian influenza began exhibiting symptoms of infection on the same day but was not tested for the virus, the CDC said.